acetic acid
Trade name: vosol
Approved
May 17, 1960
Acetic acid, systematically named ethanoic acid, is an acidic, colourless liquid and organic compound with the chemical formula CH3COOH. Vinegar is at least 4% acetic acid by volume, making acetic acid the main component of vinegar apart from water. Historically, vinegar was produced from the third century BC and was likely the first acid to be produced in large quantities. — Wikipedia
Clinical trial activity
31 trials · 45 clinical orgs · 24 marketing orgs
Earliest trial started Feb 1, 2007 (NCT00390403)
Timeline
1960s
- May 17, 1960
Hi Tech Pharmaceuticals — Earliest FDA Approval
- May 17, 1960
Hi Tech Pharmaceuticals — NDA Organization
- May 17, 1960
Hi Tech Pharmaceuticals — NDA Secondary Org
- May 17, 1960
Akorn, Inc. — NDA Secondary Org
- May 17, 1960
Hikma — Marketing Organization
- Dec 14, 1966
Bayer — Marketing Organization
- Dec 14, 1966
Bayer — NDA Secondary Org
1970s
- Jun 2, 1976
ICU Medical Inc — NDA Secondary Org
- May 10, 1977
Lumara Health — Marketing Organization
- Aug 6, 1979
B. Braun — NDA Secondary Org
- Oct 26, 1979
Warner Chilcott — Marketing Organization
1980s
- Aug 12, 1981
Actavis — Marketing Organization
- Feb 19, 1982
Baxalta — NDA Secondary Org
- Feb 19, 1982
Baxter — NDA Secondary Org
- Sep 6, 1984
Taro Pharmaceuticals — Marketing Organization
1990s
- Feb 25, 1994
Bausch & Lomb — Marketing Organization
- Jul 26, 1996
Chartwell Pharmaceuticals — Marketing Organization
- Aug 30, 1996
Wockhardt — Marketing Organization
2000s
- Feb 24, 2005
Mylan — Marketing Organization
- Feb 24, 2005
Lannett Company, Inc. — Marketing Organization
- Feb 24, 2005
Saptalis Pharmaceuticals — Marketing Organization
- Feb 24, 2005
Sciegen Pharmaceticals — Marketing Organization
- Feb 6, 2006
Cosette — Marketing Organization
- Feb 6, 2006
Vintage — Marketing Organization
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
2010s
- Mar 9, 2018
ANDA Repository — Marketing Organization
- Mar 9, 2018
Rising Pharmaceuticals — Marketing Organization
Indications
Approved for
Studied for
- Adrenocortical Carcinoma · Phase 2
- Barrett Esophagus · Phase 2/Phase 3
- Brain Neoplasms · Phase 2
- Burkitt Lymphoma · Phase 1
- Carcinoma, Hepatocellular · Phase 2
- Cognitive Dysfunction · Phase 2
- Contraceptive Devices · Phase 2
- Diabetes Mellitus, Type 2 · Phase 1/Phase 2
- Glioblastoma · Phase 2
- Gliosarcoma · Phase 2
- Hypertension, Pulmonary · Phase 2
- Intestinal Neoplasms · Phase 1
- Leukemia, Lymphocytic, Chronic, B-Cell · Phase 1/Phase 2
- Leukemia-Lymphoma, Adult T-Cell · Phase 1
- Lymphoma · Phase 1
- Lymphoma, B-Cell, Marginal Zone · Phase 1
- Lymphoma, Follicular · Phase 1
- Lymphoma, Large B-Cell, Diffuse · Phase 1
- Lymphoma, Large-Cell, Immunoblastic · Phase 1
- Lymphoma, Mantle-Cell · Phase 1
- Lymphoma, Primary Cutaneous Anaplastic Large Cell · Phase 1
- Lymphoma, T-Cell, Peripheral · Phase 1
- Lymphomatoid Granulomatosis · Phase 1
- Multiple Myeloma · Phase 1/Phase 2
- Neoplasms · Phase 1
- Prostatic Neoplasms · Phase 1/Phase 2
- Small Cell Lung Carcinoma · Phase 2
- Waldenstrom Macroglobulinemia · Phase 1
- Wounds and Injuries · Phase 1/Phase 2
Mechanism of action
- UnclearUnclear
Unclear unclear
Combination products
domeboro
with aluminum acetate
Also known as acetic acid in aqueous aluminum acetate
tridesilon
with prednisone
vosol hc
with urea
Also known as acetasol hc, acetic acid w/ hydrocortisone, hydrocortisone and acetic aci
Approval history
- approvedMay 17, 1960
Chemistry & pharmacology
SMILES
CC(=O)O- Mol. weight
- 60.05 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Topical
- Availability
- Prescription Only
Oral
No
Parenteral
No
Topical
Yes
Sources
- WikipediaAcetic acid ↗
- ChEMBLCHEMBL539 ↗
Also known as
- acetasol
- acetasol
- acetate
- acetate
- acetic acid
- acetic acid
- acetic acid
- acetic acid
- acetic acid
- acetic acid
- acetic acid
- acetic acid
- acetic acid
- acetic acid
- acetic acid, glacial
- acetic acid, glacial
- acetic acid, glacial
- acetic acid, glacial
- acetic acid, glacial
- aceticum acidum
- aceticum acidum
- acide acétique
- acide acétique
- aci-jel
- aci-jel
- e260
- e260
- earcalm
- essigsäure
- essigsäure
- ethoic acid
- ethoic acid
- ethylic acid
- ethylic acid
- ethylic acid
- glacial acetic acid
- glacial acetic acid
- hoac
- hoac
- methanecarboxylic acid
- methanecarboxylic acid
- orlex
- orlex
- vinegar acid
- vosol
- vosol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06203080 | Phase 2 | Jan 1, 2024 | Government of China |
| NCT06356480 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2023 | Government of Pakistan |
| NCT05100264 | N/A | Oct 25, 2021 | Alexandra General Hospital, Alexandra Hospital, Athens, Greece, University of Athens |
| NCT04001855 | N/A | Jul 1, 2019 | University of Arizona |
| NCT03596099 | N/A | Jul 31, 2018 | Endothelix, Mizkan Holdings Co., Ltd., Sprim Consulting, Tulane University |
| NCT02697344 | Phase 1/Phase 2 (Phase 2) | Apr 14, 2017 | Mayo Clinic, National Cancer Institute (NCI) |
| NCT02614703 | Phase 2/Phase 3 (Phase 3) | Mar 10, 2017 | Doctors Hospital at Renaissance |
| NCT02811744 | Phase 2 | Jan 1, 2017 | University of Pennsylvania |
| NCT02806115 | Phase 1 | Jun 1, 2016 | Shandong University |
| NCT02800772 | N/A | Jun 1, 2016 | Changhai Hospital |
| NCT02715583 | Early Phase 1 (Phase 1) | Mar 1, 2016 | University of Pennsylvania |
| NCT02549755 | Phase 2 | Sep 1, 2015 | Indiana University |
| NCT02420665 | N/A | Sep 1, 2015 | National Cancer Institute (NCI), National Institutes of Health (NIH), University of Texas at Houston |
| NCT02542150 | N/A | Sep 1, 2015 | University of Colorado, Denver |
| NCT02407392 | N/A | Jul 1, 2015 | Gloucestershire Hospitals NHS Foundation Trust, Portsmouth Hospitals NHS Trust, Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, University of Leicester, University of Portsmouth, University of Sussex |
| NCT02231385 | N/A | Sep 1, 2014 | Humanitas University, Istituto Clinico Humanitas - Rozzano (MI), Italy, Nuovo Regina Margherita Hospital |
| NCT02029794 | N/A | Mar 1, 2014 | Makerere University, University of British Columbia |
| NCT01003769 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2013 | Mayo Clinic, National Cancer Institute (NCI) |
| NCT01983046 | N/A | Sep 1, 2013 | Maastricht University, Top Institute Food and Nutrition |
| NCT01917136 | Phase 2 | Aug 1, 2013 | Harvard University, The Cardiovascular Medical Research and Education Fund, University of Maryland, University of Pennsylvania, Washington University in St. Louis, Yale University |
Organizations
Research & Development (45)
Marketing (29)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| ANDA Repository | For profit | MKTG | Mar 9, 2018 |
| Actavis | For profit | MKTG | Aug 12, 1981 |
| Akorn, Inc. | For profit | NDA2 | May 17, 1960 |
| B. Braun | For profit | NDA2 | Aug 6, 1979 |
| Bausch & Lomb | For profit | MKTG | Feb 25, 1994 |
| Baxalta | For profit | NDA2 | Feb 19, 1982 |
| Baxter | For profit | NDA2 | Feb 19, 1982 |
| Bayer | For profit | MKTG | Dec 14, 1966 |
| Bayer | For profit | NDA2 | Dec 14, 1966 |
| Chartwell Pharmaceuticals | For profit | MKTG | Jul 26, 1996 |
| Cosette | For profit | MKTG | Feb 6, 2006 |
| Hi Tech Pharmaceuticals | For profit | NDA | May 17, 1960 |
| Hi Tech Pharmaceuticals | For profit | NDA2 | May 17, 1960 |
| Hikma | For profit | MKTG | May 17, 1960 |
| ICU Medical Inc | For profit | NDA2 | Jun 2, 1976 |
| Lannett Company, Inc. | For profit | MKTG | Feb 24, 2005 |
| Lumara Health | For profit | MKTG | May 10, 1977 |
| Mylan | For profit | MKTG | Feb 24, 2005 |
| Pharmafair | For profit | MKTG | — |
| Rising Pharmaceuticals | For profit | MKTG | Mar 9, 2018 |
| Rising Pharmaceuticals | For profit | SYN | Mar 9, 2018 |
| Saptalis Pharmaceuticals | For profit | MKTG | Feb 24, 2005 |
| Sciegen Pharmaceticals | For profit | MKTG | Feb 24, 2005 |
| Taro Pharmaceuticals | For profit | MKTG | Sep 6, 1984 |
| Taro Pharmaceuticals | For profit | SYN | Mar 4, 1985 |
| Vintage | For profit | MKTG | Feb 6, 2006 |
| Warner Chilcott | For profit | MKTG | Oct 26, 1979 |
| Wockhardt | For profit | SYN | Jul 26, 1996 |
| Wockhardt | For profit | MKTG | Aug 30, 1996 |